US9724298B2ActiveUtilityPatentIndex 92
Method to form a dialysis composition comprising citrate, calcium and magnesium
Est. expiryMar 8, 2032(~5.7 yrs left)· nominal 20-yr term from priority
A61P 7/08A61P 13/12A61K 33/14A61K 33/06A61K 31/194A61K 9/08A61M 1/1654A61K 2300/00A61K 33/32
92
PatentIndex Score
20
Cited by
98
References
12
Claims
Abstract
A method to form a dialysis composition includes determining for a patient a prescribed calcium concentration for a dialysis fluid to be administered to the patient. The determination is made based on a non-citrate containing calcium dialysis fluid. 0.5 to 3 mM citrate and 1 to 5 mM total calcium are introduced to the dialysis fluid. The total calcium results in a calcium concentration that is 0.1 to 0.2 mM per 1 mM citrate greater than the prescribed calcium concentration. 0 to 1.5 mM total magnesium is introduced to the dialysis fluid.
Claims
exact text as granted — not AI-modifiedThe invention is claimed as follows:
1. A method to form a dialysis composition, the method comprising:
determining for a patient a prescribed calcium concentration for a dialysis fluid to be administered to the patient, wherein the determination is made based on a non-citrate containing calcium dialysis fluid;
introducing 0.5 to 3 mM citrate to the dialysis fluid,
introducing 1 to 5 mM total calcium to the dialysis fluid, wherein the total calcium results in a calcium concentration that is 0.1 to 0.2 mM per 1 mM citrate greater than the prescribed calcium concentration; and
introducing 0 to 1.5 mM total magnesium to the dialysis fluid.
2. The method of claim 1 , wherein the concentration of calcium is 0.12 to 0.18 mM per 1 mM citrate greater than the prescribed calcium concentration.
3. The method of claim 1 , wherein the introduction of the total calcium provides a constant calcium mass transport irrespective of a level of the citrate.
4. The method of claim 1 , wherein the determination of the prescribed calcium concentration determines the prescribed calcium concentration to be selected from the group consisting of 1.00 mM, 1.25 mM, 1.50 mM, and 1.75 mM.
5. The method of claim 4 , wherein the prescribed calcium concentration selected from the group consisting of 1.00 mM, 1.25 mM, 1.50 mM, and 1.75 mM results in a blood outlet total calcium value selected from the group consisting of 1.94 mM, 2.17 mM, 2.40 mM, and 2.62 mM, respectively.
6. The method of claim 1 , wherein the concentration of calcium is 1.1 to 1.2 mM per 1 mM citrate.
7. The method of claim 1 , wherein the concentration of calcium is 1.12 to 1.18 mM per 1 mM citrate.
8. The method of claim 1 , wherein the determination of the prescribed calcium concentration is based on at least one of calcium concentration and calcium mass transport for the patient.
9. The method of claim 1 comprising determining a prescribed concentration of total magnesium for the dialysis fluid, wherein the introduction of the total magnesium results in a concentration of magnesium that is 0.04 to 0.10 mM per 1 mM citrate greater than the prescribed concentration of total magnesium.
10. The method of claim 9 , wherein the determination of the prescribed magnesium concentration determines the prescribed magnesium concentration to be selected from the group consisting of 0.50 mM, 0.6 mM, and 0.75 mM.
11. The method of claim 10 , wherein the prescribed magnesium concentration selected from the group consisting of 0.50 mM, 0.6 mM, and 0.75 mM results in a blood outlet total magnesium value of 0.87 mM, 0.95 mM, and 1.07 mM, respectively.
12. The method of claim 1 , wherein the introduction of the total magnesium provides a constant magnesium mass transport irrespective of a level of the citrate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.